04:17 AM EDT, 06/04/2025 (MT Newswires) -- Trevi Therapeutics ( TRVI ) said late Tuesday it priced an offering of 17.4 million shares at $5.75 apiece, targeting gross proceeds of $100 million.
The company said it granted underwriters a 30-day option to purchase up to 2.6 million additional shares.
The company is offering all the shares in the sale, which is expected to close on or about June 5.